1-3 of 3
Paolo Gresele
Close
Sort by
Journal Articles

Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1 -mutated AML

Clinical Trials & Observations
Giulia Pianigiani, Andrea Gagliardi, Federica Mezzasoma, Francesca Rocchio, Valentina Tini, Barbara Bigerna, Paolo Sportoletti, Simona Caruso, Andrea Marra, Sara Peruzzi, Eleonora Petito, Giulio Spinozzi, Sharon Shacham, Yosef Landesman, Concetta Quintarelli, Paolo Gresele, Franco Locatelli, Maria Paola Martelli, Brunangelo Falini, Lorenzo Brunetti
Journal: Blood Advances
Blood Adv (2022) 6 (22): 5938–5949.
https://doi.org/10.1182/bloodadvances.2022007563
Published: 2022
Includes: Supplemental data
Journal Articles

A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD

Loredana Bury, Emanuela Falcinelli, Haripriya Kuchi Bhotla, Anna Maria Mezzasoma, Giuseppe Guglielmini, Alexander Tischer, Laurie Moon-Tasson, Matthew Auton, Paolo Gresele
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2236–2246.
https://doi.org/10.1182/bloodadvances.2021005463
Published: 2022
Includes: Multimedia, Supplemental data
Journal Articles

Expanding the genetic spectrum of TUBB1 -related thrombocytopenia

Verónica Palma-Barqueros, Loredana Bury, Shinji Kunishima, María Luisa Lozano, Augustín Rodríguez-Alen, Nuria Revilla, Natalia Bohdan, José Padilla, María P. Fernández-Pérez, María Eugenia de la Morena-Barrio, Ana Marín-Quiles, Rocío Benito, María F. López-Fernández, Shally Marcellini, Ana Zamora-Cánovas, Vicente Vicente, Constantino Martínez, Paolo Gresele, José M. Bastida, José Rivera
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5453–5467.
https://doi.org/10.1182/bloodadvances.2020004057
Published: 2021
Includes: Supplemental data